Effects of Lowering Dialysate Calcium Concentrations on Arterial Stiffness in Patients Undergoing Hemodialysis
3
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: We assessed changes in hemodynamic and arterial stiffness parameters following reductions of dialysate calcium concentrations in patients undergoing hemodialysis. Methods: In this prospective study, 20 patients on maintenance hemodialysis (10 females, 10 males) with dialysate calcium concentrations of 1.75 mmol/L were enrolled. At the start of the study, the dialysate calcium level was lowered to 1.50 mmol/L. Serial changes in biochemical, hemodynamic, and arterial stiffness parameters, including pulse wave velocity (PWV) and augmentation index (AIx), were assessed every 2 months for 6 months. We also examined changes in the calcification-inhibitory protein, serum fetuin‑A. Results: During the 6-month study period, serum total calcium and ionized calcium decreased consistently (9.5 ± 1.0 to 9.0 ± 0.7, p = 0.002 vs. 1.3 ± 0.1 to 1.1 ± 0.1, p = 0.035). Although no apparent changes in blood pressure were observed, heart-femoral PWW (hf-PWV) and AIx showed significant improvement (p = 0.012, 0.043, respectively). Repeatedmeasures ANOVA indicated a significant effect of lowering dialysate calcium on hf-PWV (F = 4.58, p = 0.004) and AIx (F = 2.55, p = 0.049). Accompanying the change in serum calcium, serum fetuin‑A levels significantly increased (95.8 ± 45.8pmol/mL at baseline to 124.9 ± 82.2 pmol/mL at 6 months, p = 0.043). Conclusions: Lowering dialysate calcium concentration significantly improved arterial stiffness parameters, which may have been associated with upregulation of serum fetuin‑A.
Abstract
Background/Aims: We assessed changes in hemodynamic and arterial stiffness parameters following reductions of dialysate calcium concentrations in patients undergoing hemodialysis. Methods: In this prospective study, 20 patients on maintenance hemodialysis (10 females, 10 males) with dialysate calcium concentrations of 1.75 mmol/L were enrolled. At the start of the study, the dialysate calcium level was lowered to 1.50 mmol/L. Serial changes in biochemical, hemodynamic, and arterial stiffness parameters, including pulse wave velocity (PWV) and augmentation index (AIx), were assessed every 2 months for 6 months. We also examined changes in the calcification-inhibitory protein, serum fetuin‑A. Results: During the 6-month study period, serum total calcium and ionized calcium decreased consistently (9.5 ± 1.0 to 9.0 ± 0.7, p = 0.002 vs. 1.3 ± 0.1 to 1.1 ± 0.1, p = 0.035). Although no apparent changes in blood pressure were observed, heart-femoral PWW (hf-PWV) and AIx showed significant improvement (p = 0.012, 0.043, respectively). Repeatedmeasures ANOVA indicated a significant effect of lowering dialysate calcium on hf-PWV (F = 4.58, p = 0.004) and AIx (F = 2.55, p = 0.049). Accompanying the change in serum calcium, serum fetuin‑A levels significantly increased (95.8 ± 45.8pmol/mL at baseline to 124.9 ± 82.2 pmol/mL at 6 months, p = 0.043). Conclusions: Lowering dialysate calcium concentration significantly improved arterial stiffness parameters, which may have been associated with upregulation of serum fetuin‑A.
참고문헌 (27)
- Kundhal K, "Clinical epidemiology of cardiovascular disease in chronic kidney disease", Nephron Clin Pract, 101, pp.47~52 (2005)
- Sigrist MK, "Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification", Nephrol Dial Transplant, 24, pp.3157~3162 (2009)
- Demirci MS, "The influence of dialysate calcium on progression of arterial stiffness in peritoneal dialysis patients", Perit Dial Int, 29(2), pp.15~17 (2009)
- Essalihi R, "Distinct effects of amlodipine treatment on vascular elastocalcinosis and stiffness in a rat model of isolated systolic hypertension", J Hypertens, 25, pp.1879~1886 (2007)
- Speer G, "Serum osteoprotegerin level, carotid-femoral pulse wave velocity and cardiovascular survival in haemodialysis patients", Nephrol Dial Transplant, 23, pp.3256~3262 (2008)
- Nakamura U, "Usefulness of brachial-ankle pulse wave velocity measurement: correlation with abdominal aortic calcification", Hypertens Res, 26, pp.163~167 (2003)
- Giachelli CM, "Vascular calcification mechanisms", J Am Soc Nephrol, 15, pp.2959~2964 (2004)
- Yoo SJ, "The effects of low calcium dialysate on arterial compliance and vasoactive substances in patients with hemodialysis", Korean J Intern Med, 19, pp.27~32 (2004)
- Gotch F, "Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration", Blood Purif, 29, pp.163~176 (2010)
- Kyriazis J, "Arterial stiffness alterations during hemodialysis: the role of dialysate calcium", Nephron Clin Pract, 106, pp.34~42 (2007)
- LeBeouf A, "Effects of acute variation of dialysate calcium concentrations on arterial stif fness and aor tic pressure waveform", Nephrol Dial Transplant, 24, pp.3788~3794 (2009)
- Goldsmith D, "Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease", Kidney Int, 66, pp.1315~1333 (2004)
- Shroff RC, "The vascular biology of calcification", Semin Dial, 20, pp.103~109 (2007)
- Adragao T, "Cardiovascular risk in dialysis patients: an X-ray vision on vascular calcifications", Kidney Int, 74, pp.1505~1507 (2008)
- London GM, "Arterial structure and function in end-stage renal disease", Nephrol Dial Transplant, 17, pp.1713~1724 (2002)
- Marchais S, "Arterial compliance in uraemia", J Hypertens Suppl, 7, pp.84~85 (1989)
- Ogawa O, "Brachial-ankle pulse wave velocity and symptomatic cerebral infarction in patients with type 2 diabetes: a cross-sectional study", Cardiovasc Diabetol, 2, pp.10~ (2003)
- Hatsuda S, "Regional arterial stiffness associated with ischemic heart disease in type 2 diabetes mellitus", J Atheroscler Thromb, 13, pp.114~121 (2006)
- Cheng IK, "The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder", Clin Nephrol, 40, pp.100~105 (1993)
- Lezaic V, "Effects of lowering dialysate calcium concentration on mineral metabolism and parathyroid hormone secretion: a multicentric study", Ther Apher Dial, 11, pp.121~130 (2007)
- Argiles A, "Calcium kinetics and the long-term effects of lowering dialysate calcium concentration", Kidney Int, 43, pp.630~640 (1993)
- Sage AP, "Regulatory mechanisms in vascular calcification", Nat Rev Cardiol, 7, pp.528~536 (2010)
- Lebreton JP, "Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant", J Clin Invest, 64, pp.1118~1129 (1979)
- Shroff RC, "The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis", Nephrol Dial Transplant, 23, pp.3263~3271 (2008)
- Stenvinkel P, "Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin", Kidney Int, 67, pp.2383~2392 (2005)
- Mori K, "Association of serum fetuin-A with carotid arterial stiffness", Clin Endocrinol (Oxf), 66, pp.246~250 (2007)
- Ketteler M, "Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study", Lancet, 361, pp.827~833 (2003)